1. Academic Validation
  2. Convenient route to Fmoc-homotyrosine via metallaphotoredox catalysis and its use in the total synthesis of anabaenopeptin cyclic peptides

Convenient route to Fmoc-homotyrosine via metallaphotoredox catalysis and its use in the total synthesis of anabaenopeptin cyclic peptides

  • Org Biomol Chem. 2023 Nov 22;21(45):9011-9020. doi: 10.1039/d3ob01608k.
Christopher Bérubé 1 2 Louis-David Guay 1 2 Tommy Fraser 3 Victor Lapointe 1 2 Sébastien Cardinal 3 Éric Biron 1 2
Affiliations

Affiliations

  • 1 Faculté de Pharmacie, Université Laval, Québec, Québec, Canada, G1 V 0A6. eric.biron@pha.ulaval.ca.
  • 2 Laboratory of Medicinal Chemistry, Centre de Recherche du CHU de Québec-Université Laval, 2705 Boulevard Laurier, Québec, Québec, Canada, G1 V 0A6.
  • 3 Département de Biologie, Chimie et Géographie, Université du Québec à Rimouski, 300 allée des Ursulines, Rimouski, Québec, Canada, G5L 3A1.
Abstract

Herein, we report the first solid-phase total synthesis of the natural cyclic peptide anabaenopeptin F and the use of metallaphotoredox catalysis to overcome the key challenges associated with the preparation of the non-proteinogenic amino acid homotyrosine contained in these Peptides. Starting from L-homoserine, enantiopure Fmoc-protected homotyrosine was prepared in a straightforward manner by metallaphotoredox catalysis with N-Fmoc-(S)-2-amino-4-bromobutanoic acid and 4-tert-butoxybromobenzene partners. The prepared protected amino acid was used in solid-phase peptide synthesis to achieve the total synthesis of anabaenopeptin F and establish the stereochemistry of the isoleucine residue. Protease inhibition studies with the synthesized anabaenopeptin F showed inhibitory activities against Carboxypeptidase B in the low nanomolar range. The high convergency of the synthetic methodologies paves the way for the rapid access to N-Fmoc-protected non-proteinogenic and unnatural Amino acids and the total synthesis of complex bioactive Peptides containing these Amino acids.

Figures
Products